XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer
Clinical trial NCT06353646 · RECRUITING
Trial details
- NCT number
- NCT06353646
- Sponsor
- Wu Wenming
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-12
- Primary completion
- 2026-06-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.